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Abstract
Amyloid fibril formation involves three steps; structural perturbation, nucleation and elongation. We have investigated
amyloidogenesis using prion protein as a model system and UV-light as a structural perturbant. We find that UV-exposed
prion protein fails to form amyloid fibrils. Interestingly, if provided with pre-formed fibrils as seeds, UV-exposed prion
protein formed amyloid fibrils albeit with slightly different morphology. Atomic force microscopy and electron microscopic
studies clearly show the formation of fibrils under these conditions. Circular dichroism study shows loss in helicity in UV-
exposed protein. UV-exposed prion protein fails to form amyloid fibrils. However, it remains competent for fibril extension,
suggesting that UV-exposure results in loss of nucleating capability. This work opens up possibility of segregating
nucleation and elongation step of amyloidogenesis, facilitating screening of new drug candidates for specifically inhibiting
either of these processes. In addition, the work also highlights the importance of light-induced structural and functional
alterations which are important in protein based therapeutics.
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Introduction
Transmissible Spongiform Encephalopathy is a group of
diseases such as Kuru, Creutzfeldt - Jakob disease (CJD),
Gerstmann-Straussler Syndrome (GSS), and Fatal Familial
Insomnia (FFI) characterized by neurodegeneration and deposi-
tion of amyloid plaques. Conformational transition of cellular
prion protein (PrPc) is believed to be the major cause for these
diseases [1]. It took several decades of research for the evolution of
concepts from the slow virus hypothesis [2] to the prion protein
hypothesis [1,3]. However, despite extensive research, the
controversy regarding the source of infectious agent is not yet
resolved. The role of nucleic acids [4,5], polyanions [6,7] and
lipids [8–10] is being investigated, in addition to the transformed
prion protein PrPSc in the pathogenesis.
Conformational conversion of alpha-prion protein (PrPc) to
beta-prion protein (PrPSc), accompanied by aggregation, leads to
amyloid fibril formation. Mechanistically, amyloidogenesis or the
process of amyloid formation involves three major stages -
structural perturbation, nucleation and fibril extension. Nucleation
process is the rate-limiting step due to kinetically disfavored
oligomerization (self assembly) of intermediates. These assemblies
are partially concentration-dependent [11] and show presence of
hydrophobic cooperativity in the process [12]. This rate-limiting
phase is reflected as the lag phase in kinetics of amyloid formation.
The lag in kinetics persists till the formation of a critical nucleus,
after which the reaction proceeds in favor of a rapid increase in
size [13]. Bidirectional growth of elongating fiber was observed in
this stage [14]. Binding of monomer to continuously growing fiber
and subsequent conformational change characterize this event
[15,16]. These amyloid aggregates show congo-red birefringence
and cross-b-sheet structure. The organization of these fibrils
remains the same amongst different types of proteins- unbranched
2–3 subprotofibrils (10–15 A˚) helically arrange to form protofil-
aments (protofibril) (25–30 A˚), which associate laterally or twisted
in bundle of five to form mature fibrils [17].
The pre-nucleation stage involves structural perturbation and
destabilization of the native state, thus forming non-native states or
partially unfolded intermediates (kinetic or thermodynamic
intermediates), which are prone to aggregation. Mild to harsh
conditions such as low pH [18], exposure to elevated temperatures
[19,20] exposure to hydrophobic surfaces [21], partial denatur-
ation using urea [19,22] and guanidinium chloride [23], are used
to achieve non-native states. However, natively unfolded proteins
such as a-synuclein, tau protein, yeast prion, require structural
stabilization for the formation of partially folded intermediates,
which are competent for fibril formation. Conditions for partial
stabilization include low pH [24], presence of SDS [25], elevated
temperature or chemical chaperones [26].
We have tested the possibility of UV exposure as a structural
perturbant to initiate nucleation leading to amyloid fibril
formation or aggregation using the mouse full-length prion protein
(PrP 23-231) as a model system. We find that UV exposure of PrP
leads to structural changes and amorphous aggregation. UV-
exposed PrP fails to form amyloid fibrils. Interestingly, however, it
remains competent for fibril extension if provided with pre-formed
fibrils as seeds. UV exposure, thus, appears to provide a novel
handle to segregate nucleation and fibril extension.
Results
Photo-aggregation of prion protein
Mouse full-length prion protein was exposed to near-UV light of
290 nm under constant stirring. Figure 1A (triangles) shows
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aggregation profile of prion protein upon exposure to UV light.
The curve shows lag phase of 4–5 minutes. The lag phase of this
aggregation indicates its nucleation-dependent behavior. Interest-
ingly, upon incubation with Thioflavin T, a specific amyloid
binding fluorescent probe, we did not observe enhanced
fluorescence, suggesting the formation of unordered or amorphous
aggregates (data not shown). It was further confirmed with TEM
where we did not observe the presence of any fibrils (data not
shown). We have exposed the protein to UV-light of 214, 350 and
400 nm and found no aggregation (Figure 1A).
In order to investigate the nature of this aggregation, we have
carried out aggregation in presence of urea and SDS. Upon
addition of 0.1% SDS in the completely aggregated sample, we
observed loss of scattering within a short period of time, indicating
non-covalent nature of this aggregates. Amyloidogenesis of prion
protein can be induced in 3 M urea and 1 M GdmCl with
prolonged incubation and /or addition of pre-formed fibrils as
seeds. Prion protein, in 3 M urea and 1 M GdmCl did not show
any aggregation during the period of experiment (Figure 1A).
Exposing the protein to UV-light of 290 nm, under these
conditions, also did not lead to increase in Rayleigh scattering
(Figure 1A) further, corroborating non-covalent nature of
aggregation. Intramolecular disulphide bond is shown to have a
role in the amyloidogenic process in b2-microglobulin and prion
protein [27,28]. Our preparation of full length mouse prion
protein (23-231) has an intact intramolecular disulphide bond (as
checked by the SDS-PAGE with and without b-mercaptoethanol).
We have checked the disulphide bond after the sample is exposed
to UV-light. SDS-PAGE of photo-aggregated prion protein, in the
presence and absence of b-mercaptoethanol is identical indicating
no alteration of the existing disulphide bond (Figure 1B).
Prevention of photo-aggregation by antioxidants
Upon near UV exposure, tryptophan undergoes photo oxidation
and generates N-formylkynurenine, kynurenine, and tryptamine as
oxidative products. Oxidation of protein in aerated aqueous solvent
leads to generation of several reactive oxygen species and causes
aggregation of protein. In order to understand the molecular
mechanism of the photo-aggregation of prion protein, we have
monitored this aggregation in the presence of several antioxidants.
Inhibition of amorphous aggregation in the presence of antioxidants
indicates quenching/scavenging of corresponding radicals thus,
showing its involvement in this process. We used several
antioxidants specific for different oxygen species such as L-cysteine
for singlet oxygen, superoxide dismutase (SOD) for superoxide,
mannitol for hydroxyl radical and catalase for peroxyl radical.
Figure 1C shows prevention of amorphous aggregation by
antioxidants. We observed maximum aggregation in the absence
of antioxidants. We see no effect on addition of 50 mM mannitol;
aggregation profiles in the absence and the presence of mannitol
superimpose within the experimental error, suggesting that
hydroxyl radicals perhaps are not involved in the photo-
aggregation of prion protein. Even catalase had no effect on the
extent of aggregation (Figure 1C) suggesting that peroxyl radicals
do not appear to have any role in the photo-aggregation of prion
protein. Superoxide dismutase however had some effect on the
aggregation process. Upon addition of 160 U of superoxide
dismutase (SOD), we observed ca. 45% of inhibition (,55% of
aggregation) compared to the aggregation of prion protein in the
Figure 1. Photo-aggregation of prion protein. A) Mouse full-
length prion protein (2.6 mM) in 50 mM phosphate buffer was exposed
to 290 nm of light. Scattering was measured by setting excitation and
emission monochromators at 465 nm (see materials and methods).
Photo-aggregation of prion protein at 290 nm (m). Prion protein was
exposed to light of various wavelengths in above conditions such as
214 nm (&), 350 nm (.) and 400 nm (¤). Prion protein was exposed to
light of 290 nm under amyloid condition (3 M urea and 1 M GdmCl) (b)
and unexposed prion protein under amyloid condition (c). B) SDS PAGE
of prion protein Lane1- Low Molecular weight marker (GE healthcare,
UK); Lane 2-Purified recombinant mouse full-length prion protein with
b-mercaptoethanol; Lane 3- Purified recombinant mouse full-length
prion protein without b-mercaptoethanol; Lane 4- Photo-aggregated
prion protein with b-mercaptoethanol; Lane 5- Photo-aggregated prion
protein without b-mercaptoethanol. Bands were visualized by silver
staining. C) Extent of aggregation in the presence of antioxidants is
represented as bars. Percent aggregation was calculated with respect to
aggregation of prion protein alone. All experiments were done at room
temperature. Prion protein (PrP) was used at a concentration of 2.6 mM.
The concentrations of the antioxidants used for inhibition of
aggregation were of (CYS) L-cysteine, 1 mM; (SOD) Superoxide
Dismutase, 20 mg/ml (,64 U/ml); (MAN) Mannitol, 50 mM and (CAT)
Catalase, 2.5 ng/ml (,0.895 mU/ml). * represents p,0.005: ** repre-
sents p,0.01 (using student paired‘t’ test).
doi:10.1371/journal.pone.0002688.g001
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absence of any antioxidants (Figure 1C). This inhibition suggests
some role for the superoxide ions in the photo-aggregation
process. Interestingly, presence of 1 mM of free amino acid L-
cysteine was able to completely abrogate this aggregation (97%
inhibition) (Figure 1C) suggesting the major role for singlet oxygen
in the photo-aggregation process. Taken together, our results show
that peroxyl and hydroxyl radicals do not have any role in the
photo-aggregation of prion protein. Superoxide has significant
(45%) and singlet oxygen has dramatic (97%) effect on the photo-
aggregation of prion protein.
UV-exposure alters conformation of prion protein
Prion protein shows predominance of alpha helices by far UV
CD measurements (Figure 2 inset). Due to aggregation of prion
protein upon UV-light exposure CD measurements were not
possible. However, we could record CD spectra of the UV-
exposed prion protein in amyloidogenic conditions (3 M urea and
1 M GdmCl). Under these conditions, exposure to UV-light leads
to some loss of helical structure (Figure 2 curve 1). The photo-
aggregation process of prion protein shows a lag period of 4–
5 minutes (Figure 1A) indicating accumulation of aggregation-
prone intermediates. Thus, we UV-exposed prion protein for five
minutes under partial denaturing, amyloidogenic conditions. CD
spectrum was recorded soon after the exposure. UV exposure of
about five minutes was sufficient to cause observable differences in
the far UV CD. The CD spectrum in Figure 2 (curve 2) shows
significant decrease in the helicity upon UV exposure in
comparison to prion protein under amyloidogenic condition.
Due to enhanced light scattering by urea and guanidinium
chloride, we restricted CD measurements to above 205 nm. Thus,
the CD spectral study clearly indicated the structure perturbing
effect of brief exposure to UV light.
UV-exposed prion protein fails to form amyloid de novo
In order to study the consequence of such structural perturbation
(accumulation of non-native states) on the amyloidogenic process,
we investigated amyloidogenesis of UV-exposed prion protein.
Enhanced ThT fluorescence can be measured to monitor the
process of amyloid fibril formation. Figure 3 (filled squares) shows
ThT fluorescence as a function of time of prion protein (43.4 mM) in
the presence of 3 M urea, 1 M GdmCl and 150 mM NaCl at
pH 6.8 at 37uC, (,1 mg/ml), under constant shaking at 600 rpm.
As can be seen from the Figure 3 (filled squares), the lag phase
extends to 48 hrs after which ThT fluorescence increases and
attains saturation within 120 hours. Thus, mouse full-length
unexposed prion protein forms amyloid fibrils de novo in above
conditions. Surprisingly, incubation of UV-exposed prion protein
under identical amyloid forming conditions did not result in any
increase in ThT fluorescence (Figure 3 filled circles). Even after
incubation for several days, UV-exposed prion protein did not show
fibrils in it. We checked this sample under AFM to further confirm
absence of any fibrils in this sample. Figure 3 inset A shows amyloid
fibrils of unexposed prion protein formed de novo as observed in
scanning AFM. AFM of UV-exposed prion protein does not show
formation of fibrils (Figure 3 inset B). Thus, both ThT fluorescence
and AFM clearly demonstrate the inability of UV exposed prion
protein to form amyloid fibrils de novo.
The inability of UV-exposed prion protein to form amyloid
fibrils is intriguing. In order to see if UV exposure causes loss of
available protein leading to sub-critical level, if any, we have
investigated the concentration dependence of prion protein in its
amyloidogenesis. Several concentrations ranging from 4.34 mM
(,0.1 mg/ml) to 43.4 mM (,1 mg/ml) of unexposed prion
protein were prepared for amyloid formation. All the samples
were subjected to amyloid forming conditions as described in
materials and methods. We observed rise in ThT fluorescence
after 48 hrs in 43.4 mM unexposed prion protein sample
(Figure 4A). Even at one fourth of the initial concentration (i.e.,
even if the loss were upto 75%) samples show significant increase
in ThT fluorescence indicating amyloid fibril formation. Fibrils
could be seen at this concentration in AFM as shown in Figure 4B.
Fibril formation could be seen at dilution as low as ten-fold
(4.34 mM) (data not shown). However, UV-exposed prion protein
at a very high concentration (43.4 mM) showed no fibril formation
as monitored by ThT fluorescence and AFM. Increase in ThT
fluorescence and the presence of fibrils in the samples (4.34 mM,
10.85 mM); indicate that one fourth or even one tenth of the
concentration used for the experiment is sufficient for amyloid
Figure 2. Secondary structural changes of prion protein upon
UV-exposure. Far UV CD spectra of prion protein (43.4 mM) in amyloid
forming condition (3 M urea, 1 M GdmCl, 100 mM NaCl, 20 mM
phosphate buffer, pH 6.8) before (curve 1) and after (curve 2) exposure
to UV light. Inset: Far UV CD spectrum of prion protein (43.4 mM) in
phosphate buffer.
doi:10.1371/journal.pone.0002688.g002
Figure 3. Effect of UV-exposure on amyloid fibril formation of
prion protein. Amyloid fibril formation of prion protein (43.4 mM) (&)
and UV-exposed prion protein (43.4 mM) (N) monitored by increase in
ThT fluorescence (see materials and methods). Inset: AFM image of A)
prion protein amyloid fibrils (43.4 mM) and B) UV-exposed prion protein
samples (43.4 mM).
doi:10.1371/journal.pone.0002688.g003
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formation, ruling out the trivial possibility of loss of protein as a
possible cause for the observed lack of amyloid formation with the
UV-exposed samples.
UV-exposed prion protein forms amyloid upon seeding
One of the hallmark features of amyloid formation is seeding
reaction where fragments of amyloid fibrils of protein act as seed
when mixed with monomer protein and leads to fibril extension.
Seeded fibril extension reactions have no lag periods in contrast to
de novo fibril formation. Seeding eliminates the need for nucleation.
UV-exposed prion protein loses its ability to form amyloid fibrils.
Does the UV-exposed protein remain competent for fibril
extension, under conditions where seeding is not important? In
order to test this possibility, we have generated fibrils from the
prion protein and sonicated them to make seeds and used them
with UV-exposed prion protein. Interestingly, UV-exposed
protein, with seeding, indeed showed significant increase in ThT
fluorescence (Figure 6A) indicating fibril formation. This is an
interesting result as this protein failed to form fibrils de novo (as
described earlier) but continued to elongate in the presence of
seeds of amyloid fibrils obtained from unexposed prion protein.
Figure 5A and B shows EM images of UV-exposed prion protein
compared with that of unexposed prion protein amyloid fibrils
formed in the presence of seeds.
UV-exposed prion protein fibrils show altered fibril
morphology
We further investigated fibrils morphology under these condi-
tions using electron microscopy and atomic force microscopy.
Fibrils formed from monomers of unexposed prion protein in the
seeded reaction were slender and long as shown in Figure 5A. These
fibrils showed canonical organization of fibrils with subprotofibrils
of 8.8960.355 nm twisting around each other to form protofila-
ments of 20.5760.833 nm (determined as described in materials
and methods). Contrary to this, fibrils obtained from monomers of
UV-exposed protein in seeded reactions were thick and stout and
flat in appearance and showed thickness of 3060.916 nm and
47.7262.066 nm indicating different organization of fibrils as
observed from EM image (Figure 5B). We have recoded phase
images in tapping mode AFM. Phase image was obtained to find
compactness of molecules under imaging. Compactness (or stiffness)
refers to hardness or softness of the sample. Hard samples give larger
change in phase angle; soft samples in contrast lead to smaller
changes in phase angle (please see materials and methods). The
fibrils of unexposed prion protein show phase of 37.560.358u as
observed from phase image (Figure 6B) (determined as described in
experimental procedure). In contrast, phase images of fibrils of UV-
Figure 4. A) Concentration dependence of prion protein for de novo
amyloid formation. Different concentrations of unexposed prion protein
4.34 mM (&), 10.85 mM (N), 21.7 mM (m), 32.5 mM (.), 43.4 mM (¤) and
43.4 mM (b) of UV-exposed prion protein were subjected to amyloid
forming conditions. (n = 3) B) AFM image of amyloid fibrils of prion
protein (10.85 mM) incubated in amyloid forming buffer. Fibrils are
formed even at this low concentration.
doi:10.1371/journal.pone.0002688.g004
Figure 5. EM images of fibrils of seeded reactions. Small amount of sample was placed on copper grid and stained by uranyl acetate for EM
imaging (see materials and methods). EM image of A) prion protein and B) UV-exposed prion protein. Scale bar – 500 nm.
doi:10.1371/journal.pone.0002688.g005
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exposed prion protein showed significantly low phase of
3.8260.1457u (Figure 6C and D).
Significantly lower phase for UV-exposed prion protein fibrils
indicates less compact packing (or less stiffness) of these fibrils.
These results illustrate significant change in morphology and
packing of fibrils upon UV-exposure.
Discussion
Protein misfolding and aggregation is one of the major causes of
several neurodegenerative diseases and myopathies. Molecular
understanding of the ordered aggregation, amyloid fibril forma-
tion, is critical for designing strategies to mitigate the problem.
Perturbing the system with denaturants such as urea and
guanidinium hydrochloride, lower pH etc have provided wealth
of information on amyloidogenic process. We have tested the
possibility of using UV exposure for such structural perturbation
that might initiate amyloid fibril formation. Interestingly, however,
we find that UV-exposed prion protein fails to form amyloid fibrils
de novo. We have demonstrated that this observed failure to form
amyloid fibrils is not due to loss of protein (photochemical
degradation) leading to sub-critical levels for fibril formation. We
find that UV-exposure of prion protein leads to loss of helicity.
Interestingly, UV-exposed prion protein forms fibrils when
provided with nucleus (pre-formed fibril fragments as seeds). This
clearly shows that UV-exposure leads to failure of nucleation,
separating nucleation from fibril extension.
We have exposed prion protein to UV light of 290 nm. At this
wavelength, tryptophan is the major chromophore. Other
aromatic residues and cysteine also absorb UV light however to
a lesser extent. Generation of reactive oxygen species, conforma-
tional change and photo-aggregation of c-crystallin, an eye lens
protein, are well documented [29,30]. In addition to photo-
aggregation of c-crystallin, we have earlier observed conforma-
tional dependence of the photo vulnerability of tryptophan
residues in different proteins [31]. Excitation of tryptophan and
tyrosine leads to generation of tryptophanyl and tyrosinyl radicals.
Tryptophanyl radicals lead to formation of several tryptophan
oxidative products such as N-formylkynurenine (NFK), Kynuren-
ine and tryptamine. These products, especially NFK are efficient
Figure 6. ThT fluorescecence and phase images of fibrils of seeded reactions. A) ThT fluorescence of seeded reaction of UV-exposed prion
protein using seeds of unexposed prion protein. Phase image of B) protein after seeding reaction and C) UV-exposed prion protein after seeding. D)
Enlarged phase image of UV-exposed prion protein after seeding.
doi:10.1371/journal.pone.0002688.g006
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endogenous sensitizers and at near UV light generate singlet
oxygen and superoxide radicals [32,33]. Such photochemical
processes could lead to photo-aggregation of prion protein as we
observed. Prevention of aggregation by L-cysteine, a scavenger of
singlet oxygen species [34–37] and SOD suggests that the main
causative agents are singlet oxygen and superoxide.
Oxidation is one of the factors associated with the prion
disease. Increased levels of oxidation (including glycoxidation,
peroxidation, and protein nitration) [38–40], free radical-
mediated DNA damage [41] and glial activation [42] have
been observed in sporadic CJD cases. Moreover, oxidative stress
was shown to exist in early stage of prion invasion indicating it
as a causative early agent [43]. These evidences indicate that
prion protein is present in redox-active environment and is
actively involved in redox activity. This might lead to exposure
of prion protein to various oxidative insults. A recent study
showed highly localized chemical modification of prion protein
upon oxidation mediated by hydroxyl radical [44]. Another
effect of oxidation is shown as degradation/specific cleavage of
prion protein [45,46]. We find that upon UV-induced oxidation,
prion protein leads to changes in secondary structure- decrease
in alpha-helical content. Possibly, photo-oxidation of aromatic
amino acids might lead to side chain modification leading to
conformational change and thus prion protein becomes prone to
amorphous aggregation.
Interestingly, we find that UV-exposed prion protein fails to
form amyloid fibrils under the condition in which the unexposed
prion protein readily forms amyloid fibrils. The possible reasons
for the failure of exposed prion protein to form amyloid fibrils
could be: 1) photochemical damage causing loss of available
protein leading to sub-critical level, if any, of prion protein for
amyloidogenesis, 2) incapability of UV-exposed prion protein to
participate in amyloid process probably due to loss of crucial
structure of monomers and 3) inhibitory effect of oxidized
molecule on amyloid nucleus. Our concentration-dependent
studies rule out the possibility of sub-critical protein concentration.
We find that UV-exposed protein, if provided with pre-formed
seeds, readily forms amyloid fibrils, thus ruling out the possible
inhibitory effects of photo oxidized molecules. It appears that UV-
exposure renders prion protein incapable of forming amyloid
nucleus. This clearly shows that UV-exposure leads to failure of
nucleation, separating nucleation from fibril extension.
Figure 7 schematically describes the effect of light on the
amyloidogenesis. Native, largely alpha helical, prion protein under
amyloidogenic conditions undergoes structural changes and forms
amyloid nucleus to which other monomers join to extend the
nucleus to protofibrils and subsequently thicker fibrils and amyloid
aggregates (grey arrows). UV-exposure inhibits the nucleation
process hence fibril formation. UV-exposed prion protein under-
goes some structural alterations and forms amorphous aggregates.
However, it remains competent for fibril extension reaction if
provided with pre-formed fibril seeds as nucleus albeit with slightly
different morphology (Fig 7, dark arrows).
Misfolding and aggregation of proteins are believed to be the
major cause of neurodegeneration disorders such as Alzheimer’s,
Parkinson and prion disease. Therapeutic approaches to intervene
the process met with very little success [47–50]. Current
therapeutic approaches do not address nucleation and elongation
steps separately. Our work opens up possibility of segregating
nucleation and elongation step of amyloidogenesis, facilitating
screening of new drug candidates for specifically inhibiting either
of these processes. In addition, the work also highlights the
importance of light induced structural and functional alterations
which are important in protein based therapeutics.
Materials and Methods
All chemicals and reagents were of analytical or ultra pure
grade. IPTG was obtained from Bangalore Genei (India), Urea
was procured from USB (Cleveland, Ohio), and Ampicillin was
purchased from Biochem Pharmaceutical Industries Limited
(India). Guanidinium chloride (GdmCl) was from Serva (Heidel-
berg, Germany), Protease inhibitor cocktail was from ROCHE
Diagnostics GmbH (Mannheim, Germany), Trizol was from
Gibco BRL (Grand Island, NY), NaCl was from Qualigens Fine
Chemicals (India). Mannitol was from Himedia laboratories
(India). Ni-NTA matrix was obtained from QIAGEN (GmbH,
Hilden). Other chemicals or reagents were from Sigma (St. Louis,
MO). Water used in all reactions was obtained from MilliQ,
Millipore (Bedford, MA).
Cloning and expression of PrP (23-231) gene
We have cloned PrP (23-231) from mouse brain. Mouse brain was
homogenized and total RNA was extracted using Trizol. Reverse
transcription was carried out using MMLV RT and oligo dT. Using
gene-specific primers (forward primer TGCCATATGAAA
AAGCGGCCAAA-GCCTG and reverse primer GCTTTCGAAT-
CAGCTGGATCTTCTCCCG), moPrP gene was amplified in MJ
Research Peltier thermo cycler. Blunt end cloning was done using
pMOS Blue blunt ended cloning kit (Amersham Pharmacia). Insert in
pMOS blue vector and pET21a vector (Novagen) were digested with
NdeI and HindIII and ligated by T4-DNA polymerase (Promega). E.
coli DH5a strain was transfected with the plasmid construct. Positive
colonies were screened with the help of ampicillin. The sequence of
this construct was verified using 3700ABI automated DNA
sequencer. Plasmid (PrP gene cloned in pET21a) from the positive
colonies was isolated and transformed into E.coli Rosetta DE3 strain
for protein expression.
Purification of MoPrP (23-231)
MoPrP (23-231) was purified using a Ni-NTA column as described
earlier [51] with minor modifications. Briefly, moPrP 23-231
(pET21a vector) was expressed in E.coli Rosetta DE3. After 12 h of
induction, cells were harvested, lysed and centrifuged. The insoluble
pellet was washed and dissolved in 8 M urea and 10 mM reduced
glutathione and bound to Ni-NTA matrix. On-column oxidative
folding of PrP was done by slow removal of the denaturant and the
reducing agent. Protein was eluted in 1 M imidazole and was
extensively dialyzed against MilliQ water and then concentrated.
Aliquots of protein were stored at 270uC. The protein concentra-
tions were estimated using the extinction coefficient of 2.70 at 280 nm
for a 1 mg/ml solution of moPrP (23-231). This process yielded
approx. 40 mg of protein from a 1 litre culture. The purity of the
protein was checked using silver stained SDS-PAGE and western blot
(using specific anti-prion antibody, Santacruz Biotechnology Inc.,
CA) and found it to be free of any contaminants.
Photo-aggregation of prion protein
2.5 ml of 2.6 mM of recombinant mouse full-length prion
protein was prepared in 50 mM of sodium phosphate buffer
pH 7.4 and exposed to UV light in a 3 ml capacity 1 cm quartz
cuvette with continuous stirring at room temperature (25uC). In all
aggregation reactions, these parameters were kept invariant.
Spectrofluorimeter Fluorolog-3 Model FL-3-22 with 450-W xenon
light source and double grating excitation and emission mono-
chromators from Horiba Jobin Yvon Inc. (Edison, NJ) was used to
expose the protein to UV light and monitor its aggregation. Using
the Datamax software provided by Jobin Yvon, we programmed
the machine to expose the protein sample to wavelength of
Uv-Light and Amyloidogenesis
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290 nm light for one minute with 8 nm excitation bandpass and
measure Rayleigh scattering within 15 seconds with excitation and
emission monochromators at 465 nm with 5 nm bandpass. The
measurements were carried out 30–40 times. We have exposed
prion protein to light of various wavelengths such as 214, 350 and
400 nm and found no aggregation. For inhibition of aggregation,
required amounts of antioxidants were added to the reaction prior
to light exposure. Catalase enzyme (Sigma) is stored in 2.7 M
ammonium sulphate. Mouse full-length prion protein aggregates
in high ionic strength buffers. In order to avoid such high salt
induced aggregation, we desalted the enzyme on a PD10 desalting
column (Amersham). Activity of the desalted enzyme was
determined using H2O2 assay. We have used 2.235 mU of
catalase for further experiments.
Figure 7. Schematic representation of effect of light on amyloid fibril formation of prion protein. (Please note the structures are
schematic representations).
doi:10.1371/journal.pone.0002688.g007
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Amyloid formation of prion protein
Full-length mouse prion protein was converted to its amyloid
form using procedure as described earlier [22] with minor
modifications; Bocharova et al [22] formed fibrils from the
unfolded protein. We, however, formed fibrils from the native
state. In brief, to form amyloid fibrils de novo, recombinant PrP
(43.4 mM and different dilutions as required) was incubated under
amyloid forming condition, 1 M GdmHCl, 3 M urea, 150 mM
NaCl in 20 mM phosphate buffer, pH 6.8, with continuous
shaking at 600 rpm at 37uC. In the case of seeded reactions, seeds
were made of fibrils of prion protein after sonication with 5 pulses
of 2 second duration. Seed induced amyloid was formed by the
addition of 5% (,2.17 mM) of seeds (W/W) in amyloid forming
conditions. Thioflavin T (ThT) fluorescence was monitored to
follow the kinetics of fibril formation. Prion protein (0.434 mM) in
10 mM of ThT was used to measure kinetics of amyloid formation
in HITACHI F4000 Fluorescence Spectrophotometer (with
excitation and emission monochromator set at 445 nm and
485 nm respectively and a 10 nm band pass).
Circular Dichroism studies
Far-UV CD spectra of different concentrations of unexposed
and UV- exposed prion protein were recorded using a JASCO J-
815 spectropolarimeter. Experiments were performed with
different concentrations of prion protein in amyloid forming
buffer (1 M GdmCl, 3 M Urea, and 150 mM NaCl in 20 mM
phosphate buffer, pH 6.8) using a 0.01-cm path length cell. All
spectra reported are the average of four accumulations and
corrected for blank.
Transmission Electron Microscopy (TEM)
A portion of the sample of prion protein fibrils was placed on
Formavar/carbon-coated grids (300-mesh). Excess sample was
removed and the grid was air-dried. The fibril-bearing grid was
stained with 2% (w/v) uranyl acetate for 2 minutes. Images from
randomly selected areas were captured on a film at 5,000–
25,0006 magnification on a JEOL (Tokyo, Japan) JEM-2100
LaB6 Transmission electron microscope with 100 kV accelerating
voltage. Images were processed using Digital Micrograph version
3.11.0 from Gatan Inc. (Pleasanton, CA). Only background noise
was removed from the acquired images. To calculate width of
fibrils, the image was analyzed by Histogram analysis and full
width at half maximum of the histogram peaks were taken as width
of the fibrils.
Atomic Force Microscopy
The samples were imaged with Digital Instruments Bioscope
AFM with Nanoscope IV controller using silicon probe RTESP7
having a tip radius of 10 nm and a spring constant of 20–80 N/m
(Veeco Metrology group, Santa Barbara, CA). Samples were
deposited on mica adhered to ProbeON Plus Microscope slides
(Fisher Scientific, USA) and washed repeatedly to prevent
deposition of urea and guanidinium chloride. Imaging was done
in dry tapping mode at a frequency of 285–300 kHz. All imaging
experiments were performed at a scan rate of 0.8 Hz and a drive
frequency of 285–300 kHz. Images (5126512) were processed in
Nanoscope (R) III version 5.30r1. Each scan was subjected to
second order flattening. Tilts were removed using planefit. Phase
image was captured along with height image. Phase lag of the
cantilever oscillation with that of the piezoelectric drive is used to
generate phase images in tapping mode AFM [50]. The phase
images depend on the composition, adhesion, friction, viscoelas-
ticity [52], and hardness (stiffness) [53] of the sample. We have
recoded phase images in tapping mode AFM with moderate
tapping (Asp/A0 =,0.5). Phase image was obtained to find
compactness of molecules under imaging. Compactness (or
stiffness) refers to hardness or softness of the sample. Hard sample
gives larger change in phase angle; soft samples in contrast lead to
smaller changes in phase angle [53]. In order to calculate phase of
the fibrils, the image was subjected to particle analysis, phase was
obtained throughout the scan by calculating mean phase of
arbitrary small squares of equal size spanning the area containing
fibrillar mass. The process yields mean phase angle with standard
error.
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